A new trading day began on Friday, with Outlook Therapeutics Inc (NASDAQ: OTLK) stock price up 11.20% from the previous day of trading, before settling in for the closing price of $2.41. OTLK’s price has ranged from $0.87 to $8.32 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 36.59%. Meanwhile, its annual earnings per share averaged 54.58%. With a float of $27.40 million, this company’s outstanding shares have now reached $43.48 million.
Outlook Therapeutics Inc (OTLK) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Outlook Therapeutics Inc is 38.31%, while institutional ownership is 22.49%. The most recent insider transaction that took place on Sep 26 ’24, was worth 28,446. In this transaction Chief Financial Officer of this company bought 5,000 shares at a rate of $5.69, taking the stock ownership to the 5,946 shares.
Outlook Therapeutics Inc (OTLK) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.94 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.58% per share during the next fiscal year.
Outlook Therapeutics Inc (NASDAQ: OTLK) Trading Performance Indicators
Here are Outlook Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 78.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.09, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -0.74 in one year’s time.
Technical Analysis of Outlook Therapeutics Inc (OTLK)
Looking closely at Outlook Therapeutics Inc (NASDAQ: OTLK), its last 5-days average volume was 3.75 million, which is a jump from its year-to-date volume of 0.83 million. As of the previous 9 days, the stock’s Stochastic %D was 53.72%.
During the past 100 days, Outlook Therapeutics Inc’s (OTLK) raw stochastic average was set at 82.70%, which indicates a significant increase from 72.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was higher than the 0.15 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.01, while its 200-day Moving Average is $2.09. However, in the short run, Outlook Therapeutics Inc’s stock first resistance to watch stands at $2.79. Second resistance stands at $2.91. The third major resistance level sits at $3.11. If the price goes on to break the first support level at $2.47, it is likely to go to the next support level at $2.27. Should the price break the second support level, the third support level stands at $2.15.
Outlook Therapeutics Inc (NASDAQ: OTLK) Key Stats
With a market capitalization of 119.05 million, the company has a total of 44,420K Shares Outstanding. Currently, annual sales are 0 K while annual income is -75,370 K. The company’s previous quarter sales were 1,510 K while its latest quarter income was -20,150 K.
